Shanghai, China

Lu Xiao

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations of Lu Xiao in Pharmaceutical Chemistry

Introduction

Lu Xiao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of protein kinase inhibitors. With a total of three patents to his name, Lu Xiao is recognized for his innovative approaches to drug design.

Latest Patents

Lu Xiao's latest patents include the invention of pyrrolo[3,2-c]pyridine-4-one 2-indolinone protein kinase inhibitors. These compounds are described in detail in his patent applications, which outline their chemical structure and potential pharmaceutical applications. The compounds of Formula (I) and their pharmaceutically acceptable salts are designed to serve as effective protein kinase inhibitors, with various methods for their preparation and use disclosed in the specifications.

Career Highlights

Lu Xiao is currently employed at Shanghai Hengrui Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work focuses on the development of innovative therapeutic agents that can address various medical conditions. His expertise in medicinal chemistry has positioned him as a key figure in his field.

Collaborations

Lu Xiao collaborates with notable colleagues, including Peng Cho Tang and Yidong Su. These partnerships enhance the research and development efforts within the pharmaceutical sector, contributing to the advancement of new therapeutic solutions.

Conclusion

Lu Xiao's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a leading inventor in the industry. His work continues to pave the way for new advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…